
Electrocardiographic Left Ventricular Hypertrophy
Looking Beyond Left Ventricular Mass
- 1st Edition - November 1, 2025
- Imprint: Academic Press
- Editors: Ljuba Bachárová, Niraj Varma
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 3 9 2 7 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 3 9 2 8 - 8
Electrocardiographic Left Ventricular Hypertrophy: Looking Beyond Left Ventricular Mass offers a fresh perspective on the use of electrocardiograms (ECGs) for treating left ventri… Read more
Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteThese results can be crucial for diagnostics, selecting targeted therapy, and assessing cardiovascular risk. By maximizing the potential of ECG technology, the book aims to enhance patient outcomes and bring innovation to cardiac healthcare.
- Provides an understanding of the underlying electrical phenomena in Left Ventricular Hypertrophy (LVH), along with their diagnostic and prognostic importance
- Presents new insights regarding the electrical properties of hypertrophied myocardium, indicating future research and clinical applications
- Addresses controversies around so-called "false negative" ECG results in LVH diagnosis, thereby preventing the dangers of incorrect evaluation and increased risk of death
2. Effect of volumetric and conductivity changes in the left ventricle on QRS complex morphology in simulations
3. Electrocardiographic criteria for left ventricular hypertrophy diagnosis
4. Echocardiographic diagnosis of left ventricular hypertrophy and its compatibility with ECG criteria: the “false negative” ECG
5. ST segment strain pattern in LVH
6. QT interval dynamics in LVH
7. Manifestation of surface ECG conduction abnormalities by hypertrophy
8. Clinical conditions associated with LVH
9. Arrhythmia and associated ECG characteristics in left ventricular hypertrophy
10. Electrocardiographic and echocardiographic differences in the athlete's heart: a special category
11. The discrepancy between wall thickness and myocardial mass and ECG appearances in some cardiomyopathies
12. Electrocardiographic left ventricular hypertrophy and stroke
13. Evolving LVH: heart failure
14. How far should BP be lowered in middle-aged and elderly patients with hypertension and ECG-LVH?
15. Surgical Approaches in Hypertrophic Cardiomyopathy Treatment
16. Genetic Factors Underlies Cardiac Hypertrophy and Influences Its Clinical Phenotype
17. Addition of serum biomarkers carboxy-terminal propeptide of procollagen type I (PICP) and NT-proBNP levels to electrocardiography criteria for detection of left ventricular hypertrophy: The Predimed Plus trial
18. Epidemiology, prognosis and AI-ECG
19. Artificial intelligence for detecting left ventricular hypertrophy using electrocardiography
- Edition: 1
- Published: November 1, 2025
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780443339271
- eBook ISBN: 9780443339288
LB
Ljuba Bachárová
Ljuba Bacharová, MD, MBA, DSc, is the senior research leader at the International Laser Center CVTI, and a part-time teacher at both the Slovak Medical University and the Medical School at Comenius University in Bratislava (from which she received her medical degree). Following graduation, she dedicated herself to internal medicine and medical informatics. She went on to receive her MBA degree at the Business School at University of Leeds, UK. In 2011, she received a Doctor of Sciences (DSc) for her innovative approach to the ECG diagnosis of left ventricular hypertrophy. Her main research interest is the evaluation of the cardiac electric field, from standard 2-lead ECG to modeling, 3D visualization and multimodal imaging. In 2005 she became the executive editor of the Journal of Electrocardiology, and since 2006, she has spearheaded the International Research Interdisciplinary Schools (IRIS).
NV
Niraj Varma
Niraj Varma, MD, PhD, FRCP is Professor of Medicine at Cleveland Clinic, USA. After medical school in Oxford and Edinburgh, he received specialist training in Cambridge, UK and Harvard Medical School, USA. In Boston he undertook research work leading to a PhD. He has over 25 years of clinical experience maintaining research projects; e.g. pioneering the first clinical applications of remote monitoring of implantable devices, electrocardiographic imaging (ECGI), and cardiac resynchronization algorithms. His current interests are the effects of heart size (hypertrophy and shape) in heart failure on pacing therapies. He is past president of the
International Society for Holter and Noninvasive Electrocardiology (ISHNE), currently serves on the Digital Health Committee of the Heart Rhythm Society (HRS), and is Deputy Editor of Europace journal.